Yes exactly. Califf's FDA now stepping up the ADF approvals. Explains why $ELTP is all excited by the FDA Dec 21 end-of-review for SequestOx.
Exactly why now $ELTP NH PR their Oxycontin ANDA submittal in 2017 as $ELTP is expecting SequestOx approval in early 2017, following which they can then focus on their Oxycontin ANDA submittal.